SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney ... and Stroke

被引：0
|
作者：
Yang, Taeil [1 ]
Lee, Jooyeon [1 ]
Oh, Jaewon [1 ]
机构：
[1] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Cardiovasc Res Inst,Div Cardiol, 50-1,Yonsei Ro, Seoul 03722, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2024年 / 54卷 / 09期
关键词：
D O I：
10.4070/kcj.2024.0214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：562 / 564
页数：3
相关论文
共 50 条
  • [1] Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?
    Koenigsberger, Debra
    Marquez, Alexander
    Hughes, Pamela R.
    Mullen, Rebecca
    JOURNAL OF FAMILY PRACTICE, 2021, 70 (06): : E7 - E9
  • [2] Dapagliflozin, an SGLT2 inhibitor, for diabetes
    Hanefeld, Markolf
    Forst, Thomas
    LANCET, 2010, 375 (9733): : 2196 - 2198
  • [3] A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
    Jung, Chang Hee
    Jang, Jung Eun
    Park, Joong-Yeol
    DIABETES & METABOLISM JOURNAL, 2014, 38 (04) : 261 - 273
  • [4] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [5] Kidney and heart failure outcomes associated with SGLT2 inhibitor use
    Van der Aart-van der Beek, Annemarie B.
    de Boer, Rudolf A.
    Heerspink, Hiddo J. L.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (05) : 294 - 306
  • [6] Kidney and heart failure outcomes associated with SGLT2 inhibitor use
    Annemarie B. van der Aart-van der Beek
    Rudolf A. de Boer
    Hiddo J. L. Heerspink
    Nature Reviews Nephrology, 2022, 18 : 294 - 306
  • [7] SGLT2 inhibitor dapagliflozin lowers risk of heart failure in diabetes
    Overbeck P.
    MMW - Fortschritte der Medizin, 2018, 160 (20) : 18 - 19
  • [8] LUSEOGLIFLOZIN SGLT2 Inhibitor Treatment of Diabetes
    Tiwari, A.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 637 - 643
  • [9] RE: The Efficacy and Safety of SGLT2 Inhibitor in Kidney Transplant Recipients With Diabetes
    Lim, Jeong-Hoon
    Cho, Jang-Hee
    TRANSPLANTATION, 2023, 107 (03) : E80 - E81
  • [10] SGLT2 inhibitor-related AEs differ with heart failure and diabetes
    Reactions Weekly, 2024, 2031 (1) : 11 - 11
12345